HAS2 and cancer: Decreased hyaluronan synthesis due to knockdown of HAS2 probably explains some of the anti-tumorigenic effects, but HAS2 might harbor some other mechanisms too such as regulating TGFβ-induced epithelial-mesenchymal transition or increasing cancer cell invasion by downregulation of TIMP-1 [10, 24].